Screener
Rhythm Pharmaceuticals, Inc. RYTM Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $65.61M-51.6% | $62.14M-41.4% | $54.3M-39.1% | $52.08M+9.6% | $135.59M-16.1% | ||
| $265.28M+70.7% | $278.49M+33.6% | $334.65M+44.6% | $363.97M+45.1% | $155.44M-1.3% | ||
| $40.41M+54.7% | $34.19M+91.8% | $26.08M+40.9% | $33.03M+71.1% | $26.12M+48.4% | ||
| $30.52M+61.7% | $28.65M+48.3% | $25.75M+37.4% | $22.11M+59.1% | $18.87M+57.3% | ||
| $426.56M+18.3% | $430.09M+16.5% | $466.92M+24.8% | $494.8M+45.4% | $360.68M+0.9% | ||
| $103K-65.3% | $1.07M+131% | $1.1M+74.7% | $237K-70.4% | $297K-69.5% | ||
| $4.89M-14.9% | $5.11M-14.3% | $5.32M-13.8% | $5.53M-13.4% | $5.75M-12.9% | ||
| $437.27M+17.3% | $442.32M+14.4% | $480.2M+22.4% | $506.87M+39.4% | $372.73M-2.4% | ||
| $16.17M+1.1% | $12.3M+3.2% | $13.95M+13.1% | $13.63M+179% | $15.98M+252% | ||
| $0— | $48K-96.3% | $194K-84.9% | —— | —— | ||
| $12.7M+236% | $10.13M+537% | $7.3M+373% | $5.56M— | $3.78M— | ||
| $123.59M-4.5% | $103.2M-7.7% | $105.94M-8.3% | $104.27M+6.8% | $129.46M+137% | ||
| $93.4M-11.9% | $98.34M-8.9% | $100.89M-6.8% | $103.41M— | $106.01M— | ||
| $219.97M-8.0% | $204.7M-8.5% | $210.17M-7.7% | $211.19M+0.1% | $239.15M+18.2% | ||
| 120M+187,400% | 120M+193,448% | 120M+196,621% | 67K+9.8% | 64K+6.7% | ||
| -$1.46B-16.4% | -$1.41B-16.8% | -$1.35B-17.0% | -$1.3B-17.3% | -$1.25B-17.1% | ||
| $102.98M+965% | $122.91M+549% | $139.07M+540% | $148.82M+1,227% | -$11.91M-130% | ||
| $437.27M+17.3% | $442.32M+14.4% | $480.2M+22.4% | $506.87M+39.4% | $372.73M-2.4% |
FAQ
- What are Rhythm Pharmaceuticals, Inc.'s total assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) holds $437.3M in total assets, up 17.3% year over year.
- How much debt does Rhythm Pharmaceuticals, Inc. have?
- Rhythm Pharmaceuticals, Inc. carries $109.8M in total debt against $103.0M of shareholders' equity, a debt-to-equity ratio of 1.07.
- How much cash does Rhythm Pharmaceuticals, Inc. have?
- Rhythm Pharmaceuticals, Inc. holds $65.6M in cash and equivalents.
- Can Rhythm Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 3.45 — current assets exceed current liabilities.
- Where does Rhythm Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Rhythm Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
